Key points are not available for this paper at this time.
Design
Review
SIn may improve ABPM evaluation of antihypertensive duration; leaves open clinical utility pending prospective validation.
We review the potential limitations of the two current methodologies for evaluating the duration of action of antihypertensive therapy: the smoothness index (SI) and the trough : peak ratio (TP). We propose a simple correction factor for the SI. The correction factor prevents the SI from reaching erroneous high values in situations in which the reduction in blood pressure (BP) is inadequate but very homogeneous. We refer to the corrected index as the SIn (normalized SI).
No takes yet. Share an insight, caveat, or question.
Aboy et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: